Keywords: pravastatin, reduces, secondary, events, sub-study, landmark, cholesterol

Pravastatin reduces secondary events

Article | 23 December 1998

A sub-study of the landmark Cholesterol and Recurrent Events (CARE)trial has revealed that diabetic patients with a history of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in